Antonio Jimeno, MD, PhD, leads a team describing the basic biology and potential future uses of the drug SVC112
Credit
University of Colorado Cancer Center
Usage Restrictions
None
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.